 |
 |
 |
|
Twice Daily Administration of Tenofovir Alafenamide in Combination with Rifampin: Potential for Tenofovir Alafenamide Use in HIV-TB Coinfection
|
|
|
Reported by Jules Levin
16th European AIDS Conference, October 25-27, 2017. Milan
Joseph M. Custodio, Steve K. West, Justin Lutz, Amanda Vu, Deqing Xiao, Sean Collins, Moupali Das, Brian P. Kearney, Anita Mathias






|
|
|
 |
 |
|
|